Sanofi

Total Valuation

Sanofi carries a market capitalization of 22.27B, placing it among publicly traded companies globally. Its enterprise value stands at 32.16B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Sanofi currently has 1.21B shares outstanding.

Valuation Ratios

Sanofi trades at a trailing price-to-earnings ratio of 3.66. The price-to-sales ratio is 0.30, and the price-to-book ratio stands at 0.21.

Enterprise Valuation

On an enterprise value basis, Sanofi trades at an EV/EBITDA multiple of 3.19 and an EV/FCF ratio of 2.59. The EV/Sales ratio of 0.66 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 3.19 provides insight into valuation relative to core operating earnings.

Financial Position

Sanofi maintains a current ratio of 0.99, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 33.89, indicating elevated leverage, while an interest coverage ratio of 13.79 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Sanofi posts a return on equity of 5.69 and a return on invested capital of 8.38.

Taxes

Over the trailing twelve months, Sanofi has paid 1.20B in income taxes, reflecting an effective tax rate of 22.14.

Stock Price Statistics

Sanofi's stock has declined approximately -17.19096% over the past 52 weeks. The 50-day moving average sits at 19.70, while the 200-day moving average is 20.27.

Income Statement

Over the trailing twelve months, Sanofi generated 48.92B in revenue and converted that into 3.96B in net income, yielding earnings per share of 3.30. EBITDA reached 10.07B, while operating income came in at 10.07B.

Balance Sheet

Sanofi holds 6.35B in cash and equivalents against 23.58B in total debt, resulting in a net debt position of 15.32B. Total book value stands at 69.21B, with working capital of -408.00M providing operational flexibility.

Cash Flow

Sanofi produced 11.84B in operating cash flow over the past twelve months.

Margins

Sanofi operates with a gross margin of 72.77, reflecting its pricing power and cost economics. The operating margin of 20.58 and net profit margin of 8.09 provide insight into operational efficiency.

Dividends & Yields

Scores

Sanofi posts an Altman Z-Score of 1.49, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.